• LAST PRICE
    0.4199
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.2300/ 1
  • Ask / Lots
    0.4375/ 1
  • Open / Previous Close
    0.0000 / 0.4199
  • Day Range
    ---
  • 52 Week Range
    Low 0.3753
    High 2.7500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.4359
TimeVolumeSQL
09:51 ET11630.4316
10:06 ET2000.431
10:08 ET20780.41605
10:15 ET1000.4269
10:33 ET1000.4011
10:36 ET47560.431
10:38 ET24880.43
11:56 ET24840.4289
12:12 ET2000.4228
12:14 ET1000.4278
02:00 ET3300.4185
02:07 ET2000.4012
02:09 ET2000.4193
02:21 ET1000.4013
02:32 ET1000.4198
02:39 ET1050.419899
02:48 ET1200.42
02:50 ET50900.4189
02:52 ET499090.39
02:54 ET76000.39
02:56 ET100920.4
02:57 ET2000.407149
02:59 ET184000.4007
03:01 ET152000.419
03:08 ET1050.419899
03:10 ET243000.4177
03:37 ET1060.419899
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSQL
SeqLL Inc
5.0M
-1.2x
---
United StatesABMT
Advanced Biomedical Technologies Inc
3.5M
-4.7x
---
United StatesKLYG
Kelyniam Global Inc
3.0M
-4.0x
---
United StatesMOTS
Motus GI Holdings Inc
6.3M
-0.2x
---
United StatesNVIV
InVivo Therapeutics Holdings Corp
4.1M
-0.3x
---
United StatesRMED
Ra Medical Systems Inc
6.9M
0.0x
---
As of 2022-12-02

Company Information

SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. It offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. It uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its direct RNA sequencing without conversion to complementary DNA (cDNA). The Company operates in a single business segment that includes the design, development and manufacturing of genetic analysis technologies. Its testing services are fully customizable to customers research needs and challenges. Its SeqLL technology is used for various application, such as life sciences research and development, liquid biopsy, clinical diagnostics and microbiome analysis. The tSMS platform offers a sample preparation process.

Contact Information

Headquarters
317 New Boston St Ste 210WOBURN, MA, United States 01801-6231
Phone
781-817-3755
Fax
302-636-5454

Executives

President, Chief Executive Officer, Co-Founder, Director
Daniel Jones
Chief Financial Officer
John Kennedy
Director - Engineering
Abhijeet Shinde
Director - Operations
Erik Volke
Independent Director
Patrice Milos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.0M
Revenue (TTM)
$113.6K
Shares Outstanding
11.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.36
Book Value
$0.69
P/E Ratio
-1.2x
Price/Sales (TTM)
43.9
Price/Cash Flow (TTM)
---
Operating Margin
-3,620.43%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.